Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Icecure Medical Ltd’s stock clocked out at $0.61, up 0.02% from its previous closing price of $0.61. In other words, the price has increased by $0.02 from its previous closing price. On the day, 0.72 million shares were traded. ICCM stock price reached its highest trading level at $0.62 during the session, while it also had its lowest trading level at $0.5802.
Ratios:
To gain a deeper understanding of ICCM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.90 and its Current Ratio is at 2.38. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ICCM now has a Market Capitalization of 42074452 and an Enterprise Value of 32357454. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.06 while its Price-to-Book (P/B) ratio in mrq is 4.52. Its current Enterprise Value per Revenue stands at 10.876 whereas that against EBITDA is -2.143.
Stock Price History:
The Beta on a monthly basis for ICCM is 1.12, which has changed by -0.5307692 over the last 52 weeks, in comparison to a change of 0.15196204 over the same period for the S&P500. Over the past 52 weeks, ICCM has reached a high of $1.63, while it has fallen to a 52-week low of $0.59. The 50-Day Moving Average of the stock is -13.01%, while the 200-Day Moving Average is calculated to be -35.38%.
Shares Statistics:
It appears that ICCM traded 1.03M shares on average per day over the past three months and 464280 shares per day over the past ten days. A total of 68.96M shares are outstanding, with a floating share count of 40.31M. Insiders hold about 41.31% of the company’s shares, while institutions hold 0.43% stake in the company. Shares short for ICCM as of 1765756800 were 885740 with a Short Ratio of 0.86, compared to 1763078400 on 1205633. Therefore, it implies a Short% of Shares Outstanding of 885740 and a Short% of Float of 6.23.
Earnings Estimates
Icecure Medical Ltd (ICCM) is presently subject to a detailed evaluation by 1.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.2 and -$0.2 for the fiscal current year, implying an average EPS of -$0.2. EPS for the following year is -$0.06, with 1.0 analysts recommending between -$0.06 and -$0.06.
Revenue Estimates
In. The current quarter, 1 analysts expect revenue to total $901k. It ranges from a high estimate of $901k to a low estimate of $901k. As of. The current estimate, Icecure Medical Ltd’s year-ago sales were $875kFor the next quarter, 1 analysts are estimating revenue of $2.15M. There is a high estimate of $3.4M for the next quarter, whereas the lowest estimate is $906k.
A total of 1 analysts have provided revenue estimates for ICCM’s current fiscal year. The highest revenue estimate was $3M, while the lowest revenue estimate was $3M, resulting in an average revenue estimate of $3M. In the same quarter a year ago, actual revenue was $3.29MBased on 2 analysts’ estimates, the company’s revenue will be $15.72M in the next fiscal year. The high estimate is $26.36M and the low estimate is $5.08M.
